FindMyKOL
Clinical trialNCT02092246WithdrawnPhase 3Interventional

Ultrasound Guided vs Unguided Intra-articular Knee Injections

NCT02092246 is a phase 3 interventional trial sponsored by Mayo Clinic. As of 18 Nov 2026, it was withdrawn. It studies Inflammatory Arthritis and Osteoarthritis. The registry lists an enrollment of 0 participants at 1 site in 1 country. The registry lists a start date of 31 Mar 2014 and a primary completion date of 29 Feb 2016.

SponsorMayo Clinic →Enrollment0Inflammatory ArthritisOsteoarthritis
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02092246
FieldValue
Registry IDNCT02092246
StatusWithdrawn
PhasePhase 3
Study typeInterventional trial
Lead sponsorMayo Clinic
Enrollment0
Registered sites1
Countries1
ConditionsInflammatory Arthritis and Osteoarthritis
Start31 Mar 2014
Primary completion29 Feb 2016
Study completion29 Feb 2016
Last update posted15 Oct 2015

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To determine the accuracy of unguided versus ultrasound (US) guided knee joint injections in obese patients with no clinically detectable effusion.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Minnesota, United States1 site
  • Mayo Clinic in Rochester

    Rochester

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesota: 1 siteMN1WisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02092246

Each answer restates registry values shown on this page.

What is NCT02092246?

NCT02092246 is a phase 3 interventional trial sponsored by Mayo Clinic. It studies Inflammatory Arthritis and Osteoarthritis.

Who leads NCT02092246?

The registry names Matthew Pingree, MD (principal investigator, Mayo Clinic) as the overall official.

Where does NCT02092246 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT02092246 end?

The registry lists a primary completion date of 29 Feb 2016 and a study completion date of 29 Feb 2016. The sponsor last updated the record on 15 Oct 2015.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.